Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer
Clinical trial NCT05117242 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05117242
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2024-12-02
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.